VAP

VAP Group Presents The Global Blockchain Show

Retrieved on: 
Martedì, Marzo 5, 2024
Web3, VAP, Knowledge, Cryptocurrency

Dubai, United Arab Emirates--(Newsfile Corp. - March 5, 2024) - Hosted by the VAP Group, the Global Blockchain Show is about to be held on April 16 and 17, 2024, at the Grand Hyatt in Dubai.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - March 5, 2024) - Hosted by the VAP Group, the Global Blockchain Show is about to be held on April 16 and 17, 2024, at the Grand Hyatt in Dubai.
  • This is a platform to capture influential insights from some of the best global blockchain leaders participating as speakers at the event.
  • The Global Blockchain Show is an excellent venue for exchanging insights on the future of blockchain technology.
  • Vishal Parmar, the CEO of VAP Group, believes that the Global Blockchain Show has been created with the motive of providing people with depeer knowledge on the Web3 ecosystem.

Dubai Blockchain Week Powered by Global Blockchain Show Gets Louder with Bigger Gatherings and Blockchain Events

Retrieved on: 
Lunedì, Marzo 4, 2024
Bitcoin, Crypto, Research, AI, Mining, Investment, Life, NXT TakeOver, The arts, Conference, Non-fungible token, VAP, IEEE Wireless Communications, Concrete, NFT, RWA, CPC, Learning, Organization, Fintech, VIP, Heart, Jennifer Arcuri, DAO, Decentralized finance, Cryptocurrency

Dubai, United Arab Emirates--(Newsfile Corp. - March 4, 2024) - Global Blockchain Show is pleased to announce additional Blockchain events scheduled for Dubai Blockchain Week in April 2024, featuring experts, professionals, and industry leaders.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - March 4, 2024) - Global Blockchain Show is pleased to announce additional Blockchain events scheduled for Dubai Blockchain Week in April 2024, featuring experts, professionals, and industry leaders.
  • 2024 seems to be a blessing for Dubai, with hundreds of Blockchain events scheduled to take place in April.
  • The Dubai Blockchain Week 2024, powered by VAP Group, will have some of the biggest events, making the week the most engaging and impactful in the heart of Dubai City.
  • The Global Blockchain Show will have the largest gathering in Dubai's exquisite location of Grand Hyatt Dubai from April 16 to April 17, 2024.

Sophia, the World's First Robot Citizen, to Launch VAP Group's Global AI Show in Dubai

Retrieved on: 
Martedì, Marzo 5, 2024
Cryptonite, Social media, Emotion, Workplace, AI, BPM, Hanson Robotics, Success, Life, VAP, Social behavior, History, Good, CNBC, Kryptonite

VAP Group's inaugural edition of the Dubai-based AI event draws attention from investors, AI enthusiasts, and programmers across the globe as humanoid robot Sophia takes center stage

Key Points: 
  • The event will discuss engaging topics like AI Startups: What Does Their Future Look Like and Roadmap for Success in AI.
  • While her socials are handled by a social media team with an AI dialogue system, the Global AI Show will showcase her true spirit in reality.
  • The Global AI Show has teamed up with major media outlets such as Zex PR Wire, AI Mojo, Cryptonite UAE, Lunar Strategy, and more.
  • This makes Dubai the top choice for VAP Group to bring the Global AI event to life.

David Palmer to Join Global Blockchain Show 2024 as a Speaker

Retrieved on: 
Mercoledì, Febbraio 14, 2024
Grand Hyatt Dubai, AI, Internet of things, Vodafone, Learning, VAP, DAB, Fintech, Decentralized finance, Cryptocurrency

Dubai, United Arab Emirates--(Newsfile Corp. - February 14, 2024) - Global Blockchain Show will have David Palmer, Chief Product Officer, Co-founder, Vodafone's Digital Asset Broker (DAB) Platform, Vadafone, to speak as a panelist at Grand Hyatt Dubai from 16-17 April 2024.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - February 14, 2024) - Global Blockchain Show will have David Palmer, Chief Product Officer, Co-founder, Vodafone's Digital Asset Broker (DAB) Platform, Vadafone, to speak as a panelist at Grand Hyatt Dubai from 16-17 April 2024.
  • One of the largest blockchain gatherings is all set to take place in 2024 in Dubai with the Global Blockchain Show curated by the blockchain-based organization, VAP Group.
  • The event will have world-renowned blockchain experts from various corners of the world who will unite with the agenda to promote the blockchain industry through networking, blockchain sessions, and learning.
  • David Palmer is one of the leaders in the blockchain space for Vodafone Business, a recognized Blockchain thought leader, and an expert on digital technologies, new business models, DeFi, digital identity, AI, the Metaverse, and IoT.

Global AI Show 2024 Roaring Among Other Events in Dubai

Retrieved on: 
Lunedì, Febbraio 5, 2024
Grand Hyatt Dubai, Knowledge, AI, Heart, GAIS, VAP, Oil, Ministry, Environment, Learning, Information technology, Organization

DUBAI, Feb 5, 2024 - (ACN Newswire) - As more speakers and attendees sign up for the grand Global AI Show 2024, the much-awaited event is waiting to explode its potential in April at Grand Hyatt Dubai.

Key Points: 
  • DUBAI, Feb 5, 2024 - (ACN Newswire) - As more speakers and attendees sign up for the grand Global AI Show 2024, the much-awaited event is waiting to explode its potential in April at Grand Hyatt Dubai.
  • Global AI Show 2024 is scheduled to be held at the luxurious Grand Hyatt Dubai from 16 to 17 April 2024, offering an exceptional opportunity to share ideas, uncover the potential of AI, and network in the ever-evolving AI sector.
  • VAP Group has also chosen an exquisite location for the after-party event on the popular White Beach Dubai with a breathtaking view and a chic outdoor setting.
  • With the expertise of the GAIS speakers, participants can gather valuable and unique knowledge and build perspective about the technology, ensuring everyone has useful experience from the Global AI Show.

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 January 2024

Retrieved on: 
Domenica, Febbraio 4, 2024
Civil service commission, Pneumonia, Febrile neutropenia, Eli Lilly, Triprolidine, International, Bacteria, Schizophrenia, Myelopathy, Incidence, ALD, Cefepime, Allergic rhinitis, Nasal congestion, Neutrophil, Agency, COMP, Fever, HAP, EEIG, Headache, Static pressure, Medicine, Committee, Conditional, Spinal cord, Hospital-acquired pneumonia, PTC, Neutropenia, Public, CHMP, European, AMD, Patient, Diagnosis, Marketing, RCVS, European Commission, Brain, Disease, Infection, Inflammation, Male, PRES, PRAC, Pain, Pyelonephritis, Urinary tract infection, VAP, Ageing, EMA, Geographic atrophy, Adrenoleukodystrophy, Therapy, News, INN, Duchenne muscular dystrophy, Common, Fungal infection, Vaccine

Three new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended three medicines for approval at its January 2024 meeting.The committee recommended…, Positive recommendations on new medicines, Exblifep International non-proprietary name (INN)cefepime / enmetazobactam Marketing-authorisation applicantAdvanz Pharma LimitedTherapeutic indicationTreatment of: 1)…, Ryzneuta INNefbemalenograstim alfaMarketing-authorisation applicantEvive Biotechnology Ireland LimitedTherapeutic indicationReduction in the duration of neutropenia and…, Positive recommendations on new generic medicines, Niapelf INNpaliperidoneMarketing-authorisation applicantNeuraxpharm Pharmaceuticals S.L.Therapeutic indicationTreatment of schizophreniaMore informationNiapelf: Pending…, Negative recommendations on new medicines, Nezglyal INNleriglitazoneMarketing-authorisation applicantMinoryx Therapeutics S.L.Therapeutic indicationTreatment of cerebral progression and myelopathy in male…, Syfovre INNpegcetacoplanMarketing-authorisation applicantApellis Netherlands B.V.Therapeutic indicationTreatment of geographic atrophy (GA) secondary to age-related…, Positive recommendations on extensions of indications, Abecma INNidecabtagene vicleucel Marketing-authorisation holderBristol-Myers Squibb Pharma EEIGMore informationAbecma: Pending EC decision, Prevenar 20 (previously Apexxnar) Common namepneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)Marketing-authorisation holderPfizer Europe MA EEIGMore…, Aspaveli INNpegcetacoplanMarketing-authorisation holderSwedish Orphan Biovitrum AB (publ)More informationAspaveli: Pending EC decision, Retsevmo INNselpercatinibMarketing-authorisation holderEli Lilly Nederland B.V.More informationRetsevmo: Pending EC decision, Outcome of re-examination of recommendation on non-renewal of Conditional Marketing Authorisation, Translarna INNataluren Marketing-authorisation holderPTC Therapeutics International LimitedNewsEMA confirms recommendation for non-renewal of authorisation of Duchenne…, Outcome of referral, Pseudoephedrine Marketing-authorisation holderVarious companiesMore informationPseudoephedrine-containing medicinal products, Re-examination of conclusion of referral, Synapse Labs Pvt.

Key Points: 
  • Three new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended three medicines for approval at its January 2024 meeting.The committee recommended…, Positive recommendations on new medicines, Exblifep International non-proprietary name (INN)cefepime / enmetazobactam Marketing-authorisation applicantAdvanz Pharma LimitedTherapeutic indicationTreatment of: 1)…, Ryzneuta INNefbemalenograstim alfaMarketing-authorisation applicantEvive Biotechnology Ireland LimitedTherapeutic indicationReduction in the duration of neutropenia and…, Positive recommendations on new generic medicines, Niapelf INNpaliperidoneMarketing-authorisation applicantNeuraxpharm Pharmaceuticals S.L.Therapeutic indicationTreatment of schizophreniaMore informationNiapelf: Pending…, Negative recommendations on new medicines, Nezglyal INNleriglitazoneMarketing-authorisation applicantMinoryx Therapeutics S.L.Therapeutic indicationTreatment of cerebral progression and myelopathy in male…, Syfovre INNpegcetacoplanMarketing-authorisation applicantApellis Netherlands B.V.Therapeutic indicationTreatment of geographic atrophy (GA) secondary to age-related…, Positive recommendations on extensions of indications, Abecma INNidecabtagene vicleucel Marketing-authorisation holderBristol-Myers Squibb Pharma EEIGMore informationAbecma: Pending EC decision, Prevenar 20 (previously Apexxnar) Common namepneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)Marketing-authorisation holderPfizer Europe MA EEIGMore…, Aspaveli INNpegcetacoplanMarketing-authorisation holderSwedish Orphan Biovitrum AB (publ)More informationAspaveli: Pending EC decision, Retsevmo INNselpercatinibMarketing-authorisation holderEli Lilly Nederland B.V.More informationRetsevmo: Pending EC decision, Outcome of re-examination of recommendation on non-renewal of Conditional Marketing Authorisation, Translarna INNataluren Marketing-authorisation holderPTC Therapeutics International LimitedNewsEMA confirms recommendation for non-renewal of authorisation of Duchenne…, Outcome of referral, Pseudoephedrine Marketing-authorisation holderVarious companiesMore informationPseudoephedrine-containing medicinal products, Re-examination of conclusion of referral, Synapse Labs Pvt.
  • Ltd. Marketing-authorisation holderVarious companiesMore informationSynapse

Dubai 2024 Welcomes the Pinnacle of Blockchain Innovation: The Global Blockchain Show

Retrieved on: 
Martedì, Gennaio 30, 2024
Environment, VAP, Imagination, Cryptocurrency

DUBAI, Jan 30, 2024 - (ACN Newswire) - Join the Global Blockchain Show 2024 in Dubai - an innovation hub showcasing pioneering blockchain technology and visionary experts, April 16-17.

Key Points: 
  • DUBAI, Jan 30, 2024 - (ACN Newswire) - Join the Global Blockchain Show 2024 in Dubai - an innovation hub showcasing pioneering blockchain technology and visionary experts, April 16-17.
  • The Global Blockchain Show 2024 is set to take place in the magnificent city of Dubai, which is popular for its modern architecture and innovative approach.
  • The visionaries in VAP Group are responsible for organizing Global Blockchain Show 2024, a highly anticipated global event.
  • The CEO of VAP Group, Vishal Parmar, has a bigger picture for the Global Blockchain Show 2024 than just discussing what is to come.

T2 Biosystems Announces Participation in NIH-funded Antibacterial Resistance Leadership Group (ARLG) Pilot Study for Pneumonia Patients

Retrieved on: 
Giovedì, Gennaio 18, 2024
VAP, Patient, Therapy, Infection, Pneumonia, Fungemia, Ventilator-associated pneumonia, University, Microbiology, University of Utah, COVID-19, NIH, FDA, Microbiology Spectrum, Diagnosis, Blood

LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced participation in the NIH-funded Antibacterial Resistance Leadership Group (ARLG) pilot study for pneumonia patients.

Key Points: 
  • LEXINGTON, Mass., Jan. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced participation in the NIH-funded Antibacterial Resistance Leadership Group (ARLG) pilot study for pneumonia patients.
  • The Pneumonia Direct Pilot study is a prospective, observational, diagnostic, feasibility study to determine the accuracy of multiple pathogen- and host-directed tests for the diagnosis of ventilator-associated pneumonia (VAP).
  • “I am elated that the innovative research leaders of Antibacterial Resistance Leadership Group are collaborating with T2 Biosystems to evaluate direct-from-blood diagnostic technology for the management of patients with pneumonia.
  • The extremely low level of detection by T2 Biosystems’ technology (“T2MR”) in whole blood (1 – 11 CFU/mL) has been effective in detecting secondary infections.

Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results

Retrieved on: 
Lunedì, Gennaio 22, 2024
Telemedicine, Virtual Medicine, Biotechnology, Other Health, Alternative Medicine, Managed Care, Health, General Health, Other Science, Science, United States district court, VAP, Corporation, Collection, Environment, District court, Court, Acquisition, Exercise, Novo, Growth, Bank

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the first fiscal quarter ended November 30, 2023.

Key Points: 
  • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today reported its financial results for the first fiscal quarter ended November 30, 2023.
  • Revenues were $3,891,218, representing an increase of $471,938, or 14%, from $3,419,280 for the same period in 2022.
  • Revenue from our healthcare services increased by 1.2% when comparing the revenue for the same period in 2022.
  • Upon closing of the acquisition of the Ophir Collection, the Company intends to monetize the Ophir Collection.

Global Blockchain Show Dubai: A Grand Blockchain Experts Gathering in April 2024

Retrieved on: 
Lunedì, Gennaio 15, 2024
VAP, Marketing, AI, Cryptocurrency

Dubai, United Arab Emirates--(Newsfile Corp. - January 15, 2024) - VAP Group to curate one of the biggest gatherings of blockchain experts at the Global Blockchain Show.

Key Points: 
  • Dubai, United Arab Emirates--(Newsfile Corp. - January 15, 2024) - VAP Group to curate one of the biggest gatherings of blockchain experts at the Global Blockchain Show.
  • To view an enhanced version of this graphic, please visit:
    The vibrant city, Dubai, is all set to celebrate Dubai Blockchain Week in April 2024 by hosting multiple grand events of the industry.
  • Scheduled for 16-17 April 2024, the Global Blockchain Show Dubai will be held at the luxurious Grand Hyatt Dubai.
  • The attendee list for the Global Blockchain Show comprises primarily startups and scale-ups (46%) looking to find investment and marketing prospects.